article thumbnail

Stelara (ustekinumab) alternatives: What can I take instead of Stelara?

The Checkup by Singlecare

It is a biologic drug approved by the Food and Drug Administration (FDA) to treat autoimmune diseases, including plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. A biosimilar of Stelara is available under the name Wezlana , which the FDA approved in October 2023 as an interchangeable biosimilar.